Enveda's $311M Funding: Boosting AI-Driven Drug Development
Enveda Biosciences has raised $311 million to drive AI-based drug development, focusing on nature-derived treatments for skin issues and weight management.
Latest news and articles
2 articles published
Enveda Biosciences has raised $311 million to drive AI-based drug development, focusing on nature-derived treatments for skin issues and weight management.
Vijay Pande discusses his shift from a16z to VZVC, emphasizing smaller bets, the engineering mindset in biotech, and the importance of open datasets for AI in medicine.